background: The transcription factor, octamer-binding transcription factor 4 (OCT4)/POU5F1, is expressed in embryonic stem cells, germ cells and some types of adult stem cells. Human OCT4 encodes two isoforms, OCT4A and OCT4B. While OCT4A plays a crucial role in the maintenance of stem cell properties, including pluripotency, whereas OCT4B does not. We previously reported that human myometrium contains side population cells (myoSP) with a Hoechst 33 342 low-fluorescent profile. These cells exhibit phenotypic and functional characteristics of myometrial stem cells. The objective of this study was to investigate the comparative expression of OCT4 in the stem/ progenitor cell population of the human myometrium.
Introduction
Octamer-binding transcription factor 4 (OCT4) is a member of the Pit-Oct-Unc (POU) transcription factor family (Schö ler et al., 1990a, b) . OCT4 (officially POU5F1; alternatively OCT3, OCT3/4, OTF3 and OTF4) is expressed in embryonic stem (ES) cells, germ cells, embryonal carcinoma (EC) cells, germ-cell tumors and whole embryos at different stages of development (Schö ler et al., 1990a, b; Nichols et al., 1998; Pesce and Schö ler, 2000; Niwa, 2001; Gidekel et al., 2003) . In murine embryos, expression becomes detectable at the 4-to 8-cell stage with strong nuclear localization of the protein in all blastomeres until the morula-stage embryo (Palmieri et al., 1994) . At the blastocyst stage, OCT4 protein expression remains high in the inner cell mass but is rapidly down-regulated in the trophectoderm. After implantation, OCT4 is expressed in the epiblast, is down-regulated during gastrulation, and is later confined to primordial germ cells (Pesce et al., 1998) . During human development, OCT4 expression is detected from the 4-cell stage until at least the blastocyst stage (Cauffman et al., 2006) .
OCT4 protein is a well-established master regulator of pluripotency in the inner cell mass of the mammalian blastocyst as well as in ES cells. Knock-out of OCT4 causes early lethality in mice because of the absence of an inner cell mass (Nichols et al., 1998) . Repression of OCT4 expression in cultured human and mouse ES and EC cells results in a loss of pluripotency and differentiation into trophectoderm (Martin et al., 1990; Nichols et al., 1998) , whereas transgene-mediated overexpression of OCT4 triggers differentiation of ES cells into endodermal or mesodermal structures (Niwa et al., 2000; Zeineddine et al., 2006) . Furthermore, OCT4 protein and three other factors (SOX2, KLF4 and C-MYC) are required to establish mouse and human-induced pluripotent cells that are indistinguishable from ES cells (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007) . Recently, it was reported that OCT4 alone can convert somatic cells, and adult neural stem cells into pluripotent cells (Kim et al., 2009) . Thus, OCT4 protein plays an essential (and perhaps sufficient) role in the reprogramming and maintenance of pluripotency in embryonic cells and some types of somatic cells.
In addition to embryonic cells, germ cells and germ cell tumors, OCT4 expression has been reported in several adult somatic cells, in particular adult stem cells with multipotency and self-renewal capacity (Ratajczak et al., 2007) . These observations raised the possibility that the role of OCT4 in somatic stem cells may be analogous to that in ES cells and that OCT4, therefore, might serve as a general marker of pluripotency. However, this hypothesis could not be supported in mice (Berg and Goodell, 2007) , based on a conditional knock-out study which showed that OCT4 was not essential for self-renewal of somatic stem cells (Lengner et al., 2007) . Furthermore, the existence of OCT4 pseudogenes and two splice variants, OCT4A and OCT4B, in humans has generated controversies over the expression and role of OCT4 in human somatic cells, particularly somatic tissuespecific stem/progenitor cells (Pain et al., 2005; Suo et al., 2005; de Jong and Looijenga, 2006; Liedtke et al., 2007; Cantz et al., 2008) .
Recent data suggest that tissue-specific stem cells and/or mesenchymal stem cells are present in human and murine endometrial tissues (Gargett et al., 2007 (Gargett et al., , 2008 . The label-retaining cell (LRC) approach using pulse-labeling with a DNA-specific precursor has been employed to identify adult stem cells by their quiescent and slow cycling nature. LRCs have been identified as candidate tissue-specific stem cells in vivo in murine endometrium (Chan and Gargett, 2006; Cervello et al., 2007; Szotek et al., 2007) . Approximately 10% of stromal LRCs express OCT4 (Cervello et al., 2007) , suggesting a possible role of OCT4 in endometrial stem/progenitor cells. In humans, rare cells in the endometrial stroma of 44% of women (11/25) are immunoreactive for OCT4 (Matthai et al., 2006) .
Given that the endometrium and subendometrial myometrium originate from the Müllerian ducts during embryonic life (Noe et al., 1999; Uduwela et al., 2000) , it is conceivable that cells expressing OCT4 may represent adult human myometrial stem cells. Indeed, we have previously reported that human myometrium contains distinct types of cells harboring phenotypic and functional characteristics of myometrial stem cells (Ono et al., 2007) . To better understand the role of OCT4 in human myometrial physiology and pathophysiology, this study investigated the expression and localization of OCT4 and its isoforms in human myometrium and the associated putative myometrial stem/progenitor cells.
Materials and Methods

Preparation of human myometrial cells
Normal myometrial tissues were obtained from 18 patients (range 29 -51 years old; mean age 43 years old) who underwent hysterectomy because of gynecological diseases. The use of these human specimens was approved by the Keio University Ethics Committee and all patients provided informed consent.
Human myometrial cells were isolated from the tissues as previously described (Ono et al., 2007) . In brief, the myometrial tissue was cut up manually into small pieces of ,1 mm 3 which were then incubated for 
Isolation of the myometrial side population
Myometrial side population (myoSP) and main population (myoMP) cells were isolated from human myometrial tissues positive for OCT4 expression as previously described (Ono et al., 2007) . In brief, dissociated myometrial cells were resuspended at a concentration of 2 × 10 6 cells/ml in FACS solution (calcium-and magnesium-free Hanks balanced salt solution containing 2% FBS, 1% penicillin/streptomycin and 10 mM HEPES). Hoechst 33 342 (Sigma-Aldrich) was then added at a final concentration of 5 mg/ml and the sample was incubated at 378C for 90 min. A parallel aliquot was stained with Hoechst dye in the presence of 50 mM reserpine (Sigma-Aldrich). After incubation, the cells were resuspended in 2 ml of cold FACS solution, and further incubated with 1 mg/ml propidium iodide (PI, Sigma-Aldrich) to label non-viable cells. The cells were kept on ice at all times after staining with the Hoechst 33 342 dye. The Hoechst dye-and PI-treated cells were subjected to flow cytometric cell sorting to separate myoSP and myoMP cells.
Semi-quantitative RT -PCR
Five randomly chosen myometrial samples, cultured myometrial cells and myoSP fractions were subjected to total RNA extraction and RT -PCR analysis. For RNA extraction, frozen tissue samples and collected cells were triturated and total RNA was extracted using TRIZOL Reagent according to the manufacturer's protocol (Invitrogen Ltd., Paisley, UK). RNA concentration was determined by measuring the optical density at 260 nm. About 1 mg of total RNA was reverse transcribed into first strand complementary DNA (cDNA) using superscript reverse transcriptase (Invitrogen Ltd.). The resulting cDNA was amplified by PCR using primers listed in Table I ( Niwa et al., 2000; Monk and Holding, 2001; Lee et al., 2006) . cDNAs obtained from human breast adenocarcinoma Michigan Cancer Foundation-7 (MCF-7) and human hepatocellular carcinoma HepG2 cells were used as a positive and negative controls for the expression of OCT4, respectively. Human glyceraldehyde-3-phosphatedehydrogenase (GAPDH) was amplified in parallel reactions as a housekeeping reference gene that served as an internal control for the quantity and quality of the cDNA. Amplified probes were separated on 1.5% agarose gels in the presence of ethidium bromide and visualized with the BioDoc-It system (UVP, Upland, CA, USA).
Immunohistochemistry
We used 35 fresh-frozen myometrial tissue samples from the 18 patients described above. Myometrial tissue samples were embedded on TissueTek OCT compound (Sakura Finetechnical, Tokyo, Japan). The slides were sectioned by 6 mm by Cryostats (Leica Microsystems). The samples were fixed in 4% paraformaldehyde (PFA), permeabilized with Triton X-100, then washed with phosphate-buffered saline (PBS) for 5 min. Endogenous peroxidase activity was blocked for 10 min with a 0.3% H 2 0 2 solution. The sections were washed again with PBS for 5 min. Then, tissue sections were boiled in a 0.01 M sodium-citrate retrieval solution (pH 6) diluted with PBS using a microwave oven at 500 W. Then, slides were incubated overnight at 48C with primary antibodies recognizing OCT4 [OCT4 (C-20): sc-8629, Santa Cruz Biotechnology, CA, USA], diluted 1:200 with a 0.1% bovine serum albumin (BSA)/PBS solution. Primary antibody was detected and the signal amplified using Vectastain Elite ABC kit (PK-6105; Vector Laboratories, Burlingame, CA, USA). Diaminobenzidine was used as the peroxidase substrate (SK-4100; Vector Laboratories). After counterstaining with hematoxylin, the sections were washed again and mounted.
Immunofluorescence
We performed immunofluorescent staining for OCT4 on the cultured myometrial cells as previously described (Ono et al., 2007) . In brief, myometrial cells were cytospun onto glass slides, fixed in PFA, permeabilized, blocked with BSA and incubated with anti-OCT4 antibody as mentioned above. The primary antibody was visualized by secondary antibody conjugated with Alexa Fluor 488 (Molecular Probes, Carlsbad, CA, USA), followed by counterstaining with Hoechst33258 (Sigma-Aldrich). Images were collected by using an inverted Leica DMIRE2 fluorescence microscope (Leica Microsystems, Wetzlar, Germany) equipped with a CCD camera (VB-700; Keyence, Osaka, Japan) and a Leica TCS SP2 confocal microscopy system.
Immunoblot analysis
MCF-7 cells were purchased from the American Type Culture Collection and maintained in the recommended media. Nuclear proteins from MCF-7 cells and myometrial cells were prepared as described (Schreiber et al., 1989) with minor modifications. MCF-7 cells were plated on 60 mm dishes and grown to confluence. MCF-7 cells were scraped in 400 ml of cold buffer A [20 mM HEPES (pH 7.6), 10 mM NaCl, 0.2 mM EDTA, 1.5 mM MgCl 2 , 20% glycerol, 0.1% Nonidet P-40, 1 mM DTT, and 1 mM PMSF]. Dissociated myometrial cells (5 × 10 7 cells) were resuspended in 400 ml of cold buffer A by gentle pipetting. Then, MCF-7 and myometrial cells were allowed to swell on ice for 10 min. These cells were centrifuged and the supernatants, which contained cytoplasm and RNA, were removed; the nuclear pellets were resuspended in 100 ml of ice-cold buffer B [20 mM HEPES (pH 7.6), 500 mM NaCl, 0.2 mM EDTA, 1.5 mM MgCl 2 , 20% glycerol, 0.1% Nonidet P-40, 1 mM DTT and 1 mM PMSF] and the tubes were shaken vigorously. The nuclei were allowed to swell on ice for 30 min. The mixtures were then centrifuged and the supernatants, which contained the nuclear extracts, were used for immunoblot analyses. Protein concentrations were determined using the Bio-Rad protein assay reagent with BSA as the standard. Samples of 1 mg of nuclear protein from MCF-7 cells and 10 mg from myometrial cells were run on an SDS -polyacrylamide gel and transferred to nitrocellulose. The anti-OCT4 antibody (C-20; Santa Cruz Biotechnology) and anti-OCT4A antibody (C-10; Santa Cruz Biotechnology) were used for immunodetection. Whole cell lysates from mouse EC F9 cells (Berstine et al., 1973) and nuclear extracts from the human cell line MCF-7 were used as OCT4A-and OCT4-positive controls, respectively (Schö ler et al., 1990a; Tai et al., 2005) .
Real-time RT -PCR
Quantitative PCR was performed and analysed on a capillary real-time thermocycler (Light-Cycler, Roche Diagnostics, Mannheim, Germany). Amplification was done in the presence of SYBR Green I as follows: in a 10 ml final volume, cDNA was mixed with LightCyclerw-Primer Set Human OCT4 (Search LC, Heidelberg, Germany) ( 
in myometrial stem/progenitor cells protocol was used: a pre-denaturing step at 958C for 10 min, an amplification and quantification program repeated for 35 cycles of denaturation at 958C for 10 s, annealing for 10 s at 688C and extension for 16 s at 728C. At the end of elongation at each cycle, SYBR Green I fluorescence was measured. Data were analysed using the 'Fit Point Method' in LightCycler software 3.3 (Roche Diagnostics). Relative quantification was made against serial dilution of GAPDH (Roche Diagnostics) cDNA used as a housekeeping gene.
Statistical analysis
A P-value was calculated using the unpaired Student's t-test. The differences were considered significant at P , 0.05.
Results
Expression of OCT4 mRNA and OCT4 protein in human myometrium
Myometrial samples used in this study were obtained from 18 patients who underwent hysterectomy for the reasons summarized in Table II . We first examined the expression of total OCT4 mRNA in the myometrial tissue samples using RT -PCR analysis. The primer set for total OCT4 (NM_002701) were used in this analysis. In 16 out of 18 patients (88.9%), total OCT4 mRNA expression was detected in the myometrial samples tested, although the mRNA quantities varied (Fig. 1A) . Negative results from the control reaction, in which RNA or distilled water was used instead of cDNA, argued against the presence of genomic DNA contamination. To determine whether the amplified PCR products were specific for OCT4, we isolated and sequenced the amplified products. Comparisons of the obtained sequences by nucleotide -nucleotide Blast (blastn with NCBI) confirmed that the amplified products were 218 bp fragments (nt 432-649) of the published sequence: accession number NM_203289 (GenBank). As MCF-7 cells and human endometrial tissues express OCT4 (Tai et al., 2005) , both were used as positive controls for immunoblot and RT -PCR analyses (Fig. 1A, D and E) . Immunohistochemical analyses revealed that OCT4-expressing cells were present in human myometrium, although the frequency of those cells was very low (Fig. 1B) . In 12 out of 18 patients (66.7%), OCT4 protein was detected in at least one sample of myometrial cells (Table II) . OCT4 expression did not correlate with patient age or the types of gynecologic disorders (Table II) . The very low incidence of OCT4-positive cells in the myometrium was confirmed by immunocytochemical studies of singly dispersed cells isolated from human non-pregnant myometrium (Fig. 1C, left panel) .
OCT4 is a nuclear transcription factor (Pesce and Schö ler, 2001 ). In agreement, OCT4 signals were detected in the nuclei of myometrial tissues and also in singly dispersed myometrial cells (Fig. 1B and C, respectively). We next prepared a nuclear extract from a myometrial tissue sample positive for OCT4 mRNA and subjected it to immunoblot analysis using anti-OCT4 antibody. As shown in Fig. 1D , OCT4 protein was detected in the nuclei of the myometrial cells. The expression level of myometrial OCT4 was low compared with that in MCF-7 cells, which may reflect the low frequency of OCT4-expressing myometrial cells. The expression of OCT4 mRNA became undetectable in myometrial cells after 14 days of culture (Fig. 1E) . Up-regulated expression of OCT4 and OCT4A mRNAs, but not OCT4B mRNA, in putative human myometrial stem cells OCT4 gene expression is tightly associated with an undifferentiated phenotype and the maintenance of cell pluripotency in ES cells and possibly in some types of adult somatic stem cells (Tai et al., 2005) . To explore the biological significance of OCT4 expression in the myometrium, we examined the expression levels of OCT4 mRNA in myoSP and myoMP cells. Candidates for various tissue-specific stem cells have been identified based on the SP phenotypic characteristic of the unique ability to efflux the DNA binding dye Hoechst 33342 via the ATP-binding cassette transporter G2 (ABCG2) (Goodell et al., 1996; Challen and Little, 2006; Ono et al., 2007) . MyoSP and myoMP cells were isolated from three different myometrial samples. myoSP and myoMP represented 3.91 + 1.34 and 51.8 + 8.60% of the total living cells, respectively. Representative flow cytometric data are shown in Fig. 2A . As anticipated, the myoSP fraction disappeared when reserpine (an ABCG2 blocker) was present ( Fig. 2A , right panel). We next extracted total RNA from myoSP, myoMP and unfractionated myometrial cells, and analyzed the expression levels of OCT4 using quantitative real-time RT-PCR. Figure 2B shows representative data on the kinetics of real-time PCR for GAPDH (inset) and OCT4. Quantitative analysis of the real-time PCR data revealed that OCT4 transcripts were significantly more abundant in myoSP than in myoMP (Fig. 2C) . OCT4 is expressed as two isoforms (Takeda et al., 1992) , OCT4A and OCT4B, and the former rather than the latter plays a crucial role in the maintenance of stem cell properties including pluripotency (Cauffman et al., 2006; Lee et al., 2006) . To address which isoform of OCT4 is up-regulated in myoSP, we established the presence of both OCT4A and OCT4B transcripts in myometrial tissues as well as in MCF-7 (Fig. 2D) . Semi-quantitative RT -PCR analysis then revealed that the mRNA expression levels of OCT4A and a SP-associated marker, ABCG2, were increased in myoSP compared with myoMP, whereas the expression levels of both OCT4B and GAPDH transcripts were almost constant throughout the samples (Fig. 2E) . Up-regulation of OCT4 mRNA, in particular, OCT4A mRNA, prompted us to investigate the expression of other pluripotent stem cell markers, such as KLF4, NANOG, SOX15 and BMI1. We found that all these markers were detected in both myoSP and myoMP (Fig. 2F) . However, there were no differences in their expression levels between myoSP and myoMP, suggesting that myoSP may not be pluripotent but rather more lineage-committed progenitors.
To investigate the expression of OCT4A at the protein level, we have performed immunoblot experiments using cell nuclei of whole myometrial cells instead of myoSP, because myoSP cells were so rarely present that we could not collect an adequate amount of OCT4 in myometrial stem/progenitor cells those cells. Whole cell extracts of F9 cells exhibited prominent immunoblot signals for nuclear protein OCT4A and cytosolic protein GAPDH, but not nuclear protein AP2a (Fig. 2G) . Absence of AP2a in the nuclei of F9 cells is consistent with data previously reported (Werling et al., 2001) . In contrast, AP2a and GAPDH were detectable in the nuclear and cytosol fractions of myometrial cells, respectively; however, despite several trials, we failed to detect the OCT4A protein even in the nuclear extracts of the myometrial cells (Fig. 2G) . We assume that the undetectable level of OCT4A protein may be due to its selective and exclusive distribution in myoSP cells that are very rarely present (only 2.97 + 1.13% of the whole myometrial cell population). Alternatively, it is tempting to speculate that there might exist some discrepancy between OCT4A protein and mRNA levels. The presence of OCT4A protein in myoSP cells remains to be elucidated.
Discussion
In this study, we confirmed the presence of OCT4 transcripts in 16 out of 18 myometrial tissues collected from patients with benign gynecological diseases. We detected OCT4 protein at the anticipated size in OCT4 mRNA-positive samples using immunoblot analysis. Furthermore, OCT4 protein was localized within the nuclei of myometrial cells, as determined by immunohistochemistry and immunoblot analysis. Nuclear localization of OCT4 is consistent with a possible regulatory role, perhaps maintaining myometrial stem cell pluripotency. The low number of OCT4 positive myometrial cells is consistent with the anticipated low frequency of myometrial stem cells. Real-time RT -PCR analysis revealed that OCT4 transcripts were significantly more abundant in myoSP cells than in myoMP cells. Using primer sets specifically designed to avoid detection of pseudogenes and to identify the two isoforms, we found that most OCT4 detectable in myoSP was contributed by the expression of OCT4A, and not OCT4B. As OCT4A plays a role in stem cell function (Lee et al., 2006) , up-regulation of OCT4A in myoSP substantiates the stem-like properties of myoSP cells (Ono et al., 2007) .
Several recent reports have disputed the expression of OCT4 in somatic cells and have suggested that the reported observations might simply be a misinterpretation caused by the presence of the OCT4 pseudogenes or splice variant(s) such as OCT4A and OCT4B (de Jong and Looijenga, 2006; Liedtke et al., 2007; Cantz et al., 2008) . Indeed, there exists several expressed pseudogenes in the human genome, with high similarity to the OCT4A sequence (Pain et al., 2005; Suo et al., 2005) , which raises the possibility of falsepositive results in RT -PCR experiments (Suo et al., 2005; de Jong and Looijenga, 2006; Liedtke et al., 2007) . OCT4A is currently considered a main regulator of ES cell pluripotency and self-renewal capacities. OCT4B does not share the properties of OCT4A and its function remains unknown. OCT4B does not seem to function as a transcriptional activator and is localized in the cytoplasm (Lee et al., 2006) .
Tissue-specific stem cells are found in many organs, including the bone marrow, gastrointestinal mucosa, liver, brain, prostate and skin (Morrison et al., 1999; Wright, 2000; Alison et al., 2001; BernardKargar and Ktorza, 2001; Forbes et al., 2002; Pallante et al., 2007) . These cells likely participate in the normal cell turnover of these organs and are a potential source of cells after organ injury. Furthermore, several types of adult stem cells express early developmental markers such as stage-specific embryonic antigens and transcription factors as OCT4 and NANOG (Ratajczak et al., 2007) . The presence of these stem cells in various adult tissues supports the concept that adult tissues contain stem cells remaining from early gastrulation.
Given the expression of OCT4A in myoSP, these cells are highly likely to correspond to human myometrial stem cells. Indeed, myoSP display an undifferentiated status, and lack smooth muscle cell markers and ovarian steroid hormone receptors upon isolation (Ono et al., 2007) . Furthermore, they can generate oxytocin receptorpositive smooth muscle cells in the pregnant mouse uterus following xenotransplantation (Ono et al., 2007) . These results collectively suggest that myoSP cells are myometrial progenitor/stem cells, involved at least in myometrial remodeling during pregnancy.
The intracellular quantity of OCT4 determines the fate of differentiation, particularly in ES cells (Niwa et al., 2000) . Thus, it is conceivable that the level of expression of OCT4A may determine how (or when) myoSP cells are differentiated to the myometrial cell lineage. Indeed, OCT4 expression in myometrial cells containing myoSP and myoMP fractions became undetectable after 14 days of culture (Fig. 1E) , suggesting spontaneous differentiation of myoSP and/or the inability to maintain primitive cells in culture (Ono et al., 2007) . Total OCT4 and OCT4A are both detected as the mRNA level in myometrium (Figs. 1A, 2C -E) . Furthermore, we have revealed that total OCT4 is detected as protein in myometrium (Fig. 1B -D) . However, OCT4A has not been detected as protein (Fig. 2G) . It is considered that OCT4A protein in myometrium is undetectable because OCT4A positive cells are extremely rare in the myometrium and myoSP fraction. The differences between mRNA and protein were seen while analysing the OCT4, OCT4A and OCT4B, which may be due to the possible post-transcriptional regulation and scarcity of OCT4, OCT4A and OCT4B protein in myometrium. In addition, the differences were seen in OCT4, OCT4A and OCT4B in myoSP and myoMP. It is speculated that myoMP, which is heterogeneous group, has at least two groups of cell population. One is the population that expresses both OCT4A and OCT4B, and the other is a population that expresses neither. The latter population is considered to occupy a large portion of myoMP. It remains to be elucidated if new methods which can purify OCT4A positive cells effectively. Lastly, we investigated the mRNA expression of other stem cell markers, i.e. KLF4, NANOG, SOX15 and BMI1 in myometrium. These markers were detectable in both myoSP (stem cell population) and myoMP (non-stem cell population). Our data suggest that these markers could not be used as stem cell markers in myometrium (Fig. 2F) . We consider that only OCT4 may be used as a stem cell marker in myometrium.
OCT4 has been implicated in tumorigenesis (Ezeh et al., 2005; Gibbs et al., 2005; Ponti et al., 2005; Tai et al., 2005; Trosko, 2006; Atlasi et al., 2007; Zangrossi et al., 2007) . OCT4 has the potential to transform non-tumorigenic cells and endow tumurigenicity in a dose-dependent manner (Gidekel et al., 2003) . However, the significance of this observation remains clouded because it is not known which isoform was responsible (Atlasi et al., 2007 (Atlasi et al., , 2008 Cantz et al., 2008; Mueller et al., 2009; Papamichos et al., 2009) . Given the expression of OCT4A in putative myometrial progenitor/stem cells, the results of this study raise the possibility that myometrial OCT4 may participate not only in myometrial physiology but also in neoplastic processes, including pathogenesis of leiomyoma or sarcoma in the human uterus. It remains to be determined whether the frequency of OCT4-postive cells in myometrium determines susceptibility to tumorigenesis.
Our data indicates that relatively few myometrial cells express OCT4 protein. This distinct population presumably corresponds to myometrial stem/progenitor cells in human myometrium. The data are consistent with OCT4 being a candidate as a marker for myometrial stem/progenitor cells in human myometrium.
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